Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: Role of nitric oxide

Journal of Investigative Medicine

Volumn 48, Issue 3, 2000, Pages 183-189

  Romano, M ^a   Mezzetti, A ^a   Marulli, C ^a   Ciabattoni, G ^a   Febo, F ^a   Di Lenno, S ^a   Roccaforte, S ^a   Vigneri, S ^a   Nubile, G ^a   Milani, M ^a   Davi, G ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Endothelial activation; Fluvastatin; Hypercholesterolemia; Thromboxane

Indexed keywords

11 OXOTHROMBOXANE B2; CELL ADHESION MOLECULE; CREATININE; FLUINDOSTATIN; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; PADGEM PROTEIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; RANDOMIZED CONTROLLED TRIAL;

EID: 0033782877     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. The pathogenesis of atherosclerosis: A perspective for the 1990s
2. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo
3. Vascular endothelial dysfunction
4. Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia
5. Leukocyte-endothelial adhesion molecules
6. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation
7. PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells
8. PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes
9. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice
10. Intercellular adhesion molecule-1
11. Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1
12. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques
13. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice
14. Increased levels of soluble P-selectin in hypercholesterolemic patients
15. Levels of soluble cell adhesion molecules in patients with dyslipidemia
16. Cholesterol reduction yields clinical benefit. Impact of statin trials
17. A review of current clinical findings with fluvastatin
18. Classification of hyperlipidemias and hyperlipoproteinemias
19. Enzymatische bestimmung des gesamtecholesterins in serum
20. Triglyceride determination after enzymatic hydrolysis
21. Cholesterol determination in the HDL separated by precipitation with polianions
22. Estimation of the concentration of low density lipoproteins cholesterol in plasma, without use of the preparative ultracentrifuge
23. 2 in human plasma and urine
24. 2 in man
25. Nitric oxide and its role in the cardiovascular system
26. Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia
27. Alternatively spliced isoform of P-selectin is present in vivo as a soluble molecule
28. Absence of P-selectin delays fatty streak formation in mice
29. Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia
30. Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets
31. 2(α), is increased in hypercholesterolemia
32. Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL
33. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
34. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice
35. 4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in apoE-deficient mice
36. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis
37. Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line
38. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta
39. 3- levels in patients with hypercholesterolemia
40. Modulation of P-selectin expression on isolated human platelets by an NO donor assessed by a novel ELISA application
41. Simvastatin, an HMGcoenzyme A reductase inhibitor, improves endothelial function within 1 month
42. Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors
43. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells
44. Clinical use of the measurement of soluble ceil adhesion molecules in patients with autoimmune rheumatic diseases